Back to search

Article

Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH

2021-09-14

Abstract excerpt

The role of EGFR in lung cancer is well described with numerous activating mutations that result in phosphorylation and tyrosine kinase inhibitors that target EGFR. While the role of the EGFR kinase in non-small cell lung cancer (NSCLC) is appreciated, control of EGFR signaling pathways through dephosphorylation by phosphatases is not as clear. In recent work we identified mutations in Protein Tyrosine Phosphatase...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9b060fdd-45cf-5cb6-ba10-faaab8d8c76a
DOI
10.1101/2021.09.14.460311
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRHDOI 10.1101/2021.09.14.460311
Select a neighboring publication to make it the new centre.